Martin Kelly
MALIN CORP, the life sciences group floated in 2015, is one of the strangest corporate entities ever to feature on the Irish Stock Exchange, with a remuneration strategy the board/executives might believe to be fair game but which is almost impossible to decipher. What is clear is that the company’s principals are doing very well... Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!
